Mithra Pharmaceuticals Future Growth
Future criteria checks 5/6
Mithra Pharmaceuticals is forecast to grow earnings and revenue by 32.4% and 26.3% per annum respectively. EPS is expected to grow by 42.8% per annum. Return on equity is forecast to be 13.6% in 3 years.
Key information
32.4%
Earnings growth rate
42.8%
EPS growth rate
| Pharmaceuticals earnings growth | 23.9% |
| Revenue growth rate | 26.3% |
| Future return on equity | 13.6% |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 184 | 64 | 42 | 78 | 4 |
| 12/31/2023 | 128 | -33 | -6 | -12 | 4 |
| 12/31/2022 | 150 | 65 | 67 | 126 | 4 |
| 6/30/2022 | 22 | -93 | -99 | -76 | N/A |
| 3/31/2022 | 22 | -105 | -97 | -75 | N/A |
| 12/31/2021 | 23 | -117 | -96 | -74 | N/A |
| 9/30/2021 | 21 | -115 | -93 | -74 | N/A |
| 6/30/2021 | 19 | -113 | -91 | -73 | N/A |
| 3/31/2021 | 14 | -103 | -94 | -77 | N/A |
| 12/31/2020 | 9 | -92 | -96 | -80 | N/A |
| 9/30/2020 | 44 | -31 | -85 | -70 | N/A |
| 6/30/2020 | 79 | 29 | -73 | -59 | N/A |
| 3/31/2020 | 88 | 1 | -68 | -53 | N/A |
| 12/31/2019 | 97 | -27 | -62 | -47 | N/A |
| 9/30/2019 | 84 | -54 | -42 | -28 | N/A |
| 6/30/2019 | 71 | -82 | -21 | -5 | N/A |
| 3/31/2019 | 64 | -55 | -14 | -1 | N/A |
| 12/31/2018 | 58 | -28 | -7 | 4 | N/A |
| 9/30/2018 | 46 | -41 | -23 | -9 | N/A |
| 6/30/2018 | 33 | -53 | -40 | -25 | N/A |
| 3/31/2018 | 33 | -46 | -44 | -28 | N/A |
| 12/31/2017 | 32 | -38 | -47 | -31 | N/A |
| 9/30/2017 | 26 | -37 | -47 | -32 | N/A |
| 6/30/2017 | 20 | -36 | -46 | -32 | N/A |
| 3/31/2017 | 21 | -36 | -43 | -28 | N/A |
| 12/31/2016 | 22 | -35 | -40 | -23 | N/A |
| 9/30/2016 | 21 | -29 | -35 | -23 | N/A |
| 6/30/2016 | 20 | -23 | -31 | -22 | N/A |
| 3/31/2016 | 20 | -16 | N/A | -20 | N/A |
| 12/31/2015 | 20 | -10 | N/A | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MITP.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: MITP.F is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: MITP.F is expected to become profitable in the next 3 years.
Revenue vs Market: MITP.F's revenue (26.3% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: MITP.F's revenue (26.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MITP.F's Return on Equity is forecast to be low in 3 years time (13.6%).